From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative Review

被引:4
作者
Wagner, Morgan L. [1 ]
Pergolizzi Jr, Joseph [2 ]
LeQuang, Jo Ann K. [3 ]
Breve, Frank [4 ]
Varrassi, Giustino [5 ]
机构
[1] Entrepreneur Program, NEMA Res Inc, Naples, FL USA
[2] NEMA Res Inc, Operat, Naples, FL USA
[3] NEMA Res Inc, Operat, Naples, FL 34108 USA
[4] Temple Univ, Pharm, Philadelphia, PA USA
[5] Paolo Procacci Fdn, Pain Management, Rome, Italy
关键词
overdose; antidepressant; gas station heroin; street drug; tianna red; zaza; tianeptine; ABUSE; EFFICACY;
D O I
10.7759/cureus.40688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tianeptine is often incorrectly described as a selective serotonin reuptake inhibitor, but it actually is a & mu;-opioid receptor agonist with anxiolytic effects. It has been approved since the last 1980s in about 24 countries as a treatment for depression, but it was never cleared to market in the United States for this purpose. Nevertheless, tianeptine joined the billion-dollar US market of nootropics as ZaZa or Tianna Red and is widely available online and in small shops without a prescription, to the point that it has been nicknamed "gas station heroin." While the therapeutic dose range is about 25 to 50 mg/day, tianeptine abusers may take 100 times that amount. Tolerance occurs rapidly and users who seek to recapture the short-lived euphoric effects of the drug have to take more and more. Social media has peer-support sites for those trying to discontinue tianeptine. Tianeptine is associated with multiple side effects at high doses along with dependence, withdrawal symptoms, toxicity, respiratory depression, and even mortality. Agitation is more often a presenting symptom of withdrawal than toxicity. Tianeptine is often used by polysubstance drug abusers who may be unaware of the drug's dangers. Few clinicians are aware of tianeptine and most urine assays do not screen for it. Greater awareness is needed for this drug and steps must be taken as tianeptine or "gas station heroin" is emerging as a new public health threat.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Controlling for Drug Dose in Systematic Review and Meta-Analysis: A Case Study of the Effect of Antidepressant Dose
    Hansen, Richard A.
    Moore, Charity G.
    Dusetzina, Stacie B.
    Leinwand, Brian I.
    Gartlehner, Gerald
    Gaynes, Bradley N.
    MEDICAL DECISION MAKING, 2009, 29 (01) : 91 - 103
  • [32] Ototoxic hearing loss from antimalarials: A systematic narrative review
    Dillard, Lauren K.
    Fullerton, Amanda M.
    McMahon, Catherine M.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 43
  • [33] A Systematic Review of Risk Factors and Consequences of Nyaope Usage: The Illicit Street Drug Containing HIV Antiretrovirals
    Varshney, Karan
    Browning, Samuel D.
    Debnath, Sujit K.
    Shet, Pavan
    Shet, Darshan
    AIDS AND BEHAVIOR, 2023, 27 (02) : 558 - 577
  • [34] Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
    Colla, Michael
    Scheerer, Hanne
    Weidt, Steffi
    Seifritz, Erich
    Kronenberg, Golo
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2021, 15
  • [35] A narrative review: Ultrasound-Assisted drug delivery: Improving treatments via multiple mechanisms
    Tao, Wenxin
    Lai, Yubo
    Zhou, Xueying
    Yang, Guodong
    Wu, Pengying
    Yuan, Lijun
    ULTRASONICS, 2025, 151
  • [36] Psychosocial factors associated with overdose subsequent to Illicit Drug use: a systematic review and narrative synthesis
    Byrne, Christopher J.
    Sani, Fabio
    Thain, Donna
    Fletcher, Emma H.
    Malaguti, Amy
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [37] Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review
    Rossi, Mariateresa
    Ferrucci, Silvia M.
    Calzavara-Pinton, Piergiacomo
    Marzano, Angelo V.
    Peris, Ketty
    Nicoli, Elena
    Moretti, Devis
    Chiricozzi, Andrea
    ADVANCES IN THERAPY, 2025, 42 (01) : 94 - 105
  • [38] Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
    Iniesta, Raquel
    Hodgson, Karen
    Stahl, Daniel
    Malki, Karim
    Maier, Wolfgang
    Rietschel, Marcella
    Mors, Ole
    Hauser, Joanna
    Henigsberg, Neven
    Dernovsek, Mojca Zvezdana
    Souery, Daniel
    Dobson, Richard
    Aitchison, Katherine J.
    Farmer, Anne
    McGuffin, Peter
    Lewis, Cathryn M.
    Uher, Rudolf
    SCIENTIFIC REPORTS, 2018, 8
  • [39] Novel approaches to drug-placebo difference calculation: evidence from short-term antidepressant drug-trials
    Rihmer, Zoltan
    Gonda, Xenia
    Doeme, Peter
    Erdos, Peter
    Ormos, Mihaly
    Pani, Luca
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (4-5) : 307 - 312
  • [40] Diabetic Neuropathy: a Critical, Narrative Review of Published Data from 2019
    Nagpal, Ameet S.
    Leet, Jennifer
    Egan, Kaitlyn
    Garza, Rudy
    CURRENT PAIN AND HEADACHE REPORTS, 2021, 25 (03)